EUVIMEDEUVIMED entdecken
Open Access

TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease

Haritha L Desu, Estrid Thougaard, Brianna N Carney, Placido Illiano, Melanie J Plastini, Yoleinny Florimon, Antonella Mini, Chelsea Guastucci, Brian Kang, Jae K Lee, Kate L Lambertsen, Roberta Brambilla

Brain, Behavior, and Immunity · 2025

DOI: 10.1016/j.bbi.2024.09.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025. Verfasst von Haritha L Desu und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type II, Multiple Sclerosis, Microglia, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Independent Research Fund Denmark, Odense Universitetshospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Sclerosis (MS) is a chronic degenerative disease of the central nervous system (CNS) characterized by inflammation, demyelination, and progressive neurodegeneration. These processes, combined with the failure of reparative remyelination initiated by oligodendrocyte precursor cells (OPCs), lead to irreversible neurological impairment. The cytokine tumor necrosis factor (TNF) has been implicated in CNS repair via activation of its cognate receptor TNFR2 in glia. Here, we demonstrate the important role of TNFR2 in regulating OPC function in vivo during demyelinating disease, and that TNFR2 expressed in OPCs modulates OPC-microglia interactions. In PdgfrαCreERT:Tnfrsf1bfl/fl:Eyfp mice with selective TNFR2 ablation in OPCs, we observed an earlier onset and disease peak in experimental autoimmune encephalomyelitis (EAE). This was associated with accelerated immune cell infiltration and increased microglia activation in the spinal cord. Similarly, PdgfrαCreERT:Tnfrsf1bfl/fl:Eyfp mice showed rapid and increased microglia reactivity compared to control mice in the corpus callosum after cuprizone-induced demyelination, followed by chronic reduction in the number of mature myelinating oligodendrocytes (OLs). With EAE and cuprizone models combined, we uncovered that TNFR2 does not have a cell autonomous role in OPC differentiation, but may be important for survival of newly formed mature OLs. Finally, using an in vitro approach, we demonstrated that factors released by Tnfrsf1b ablated OPCs drove microglia to develop an exacerbated "foamy" phenotype when incubated with myelin-rich spinal cord homogenate, aberrantly increasing lysosomal lipid accumulation. Together, our data indicate that TNFR2 signaling in OPCs is protective by dampening their immune-inflammatory activation and by suppressing neurotoxic microglia reactivity. This suggests that boosting TNFR2 activation or its downstream cascades could be an effective strategy to restore OPC reparative capacity in neuroimmune and demyelinating disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Tumor Necrosis Factor, Type IIMultiple SclerosisMicrogliaEncephalomyelitis, Autoimmune, ExperimentalOligodendrocyte Precursor CellsAnimalsMiceMice, TransgenicSignal TransductionCell SurvivalCuprizoneCell DifferentiationMice, Inbred C57BLMaleFemaleCorpus Callosum

Stichwörter der Autor:innen

ImmunomodulationMicrogliaMultiple sclerosisNeuroinflammationOPCsRemyelinationTNFR2

Substanzen

Tnfrsf1b protein, mouseReceptors, Tumor Necrosis Factor, Type IICuprizone

Autor:innen und Institutionen

  • The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Department of Neurobiology Research, Institute of Molecular Medicine, Univers…
  • Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5230 Odense M, Denmark; BRIDGE-Brain Research Inter Disciplinary Guided Excellence, Department of Clinical Research,…

Förderung

  • NINDS NIH HHS
  • Independent Research Fund Denmark
  • Odense Universitetshospital
  • Danish Multiple Sclerosis Society
  • Buoniconti Fund to Cure Paralysis
  • The AP Møller Support Foundation
  • Novo Nordisk Foundation
  • Danmarks Frie Forskningsfond

Zitieren

APA

Desu, H. L., Thougaard, E., Carney, B. N., Illiano, P., Plastini, M. J., Florimon, Y., Mini, A., Guastucci, C., Kang, B., Lee, J. K., Lambertsen, K. L., & Brambilla, R. (2025). TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.09.002

Vancouver

Desu HL, Thougaard E, Carney BN, Illiano P, Plastini MJ, Florimon Y, et al. TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease. Brain, Behavior, and Immunity. 2025. doi:10.1016/j.bbi.2024.09.002

BibTeX
@article{Desu2025,
  author = {Desu, Haritha L and Thougaard, Estrid and Carney, Brianna N and Illiano, Placido and Plastini, Melanie J and Florimon, Yoleinny and Mini, Antonella and Guastucci, Chelsea and Kang, Brian and Lee, Jae K and Lambertsen, Kate L and Brambilla, Roberta},
  title = {TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease},
  journal = {Brain, Behavior, and Immunity},
  year = {2025},
  doi = {10.1016/j.bbi.2024.09.002}
}
Kostenlos starten →